Kudos

Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company

25 Jan 17 Kuros Biosciences (SIX:KURN) today announced the closing of the all-share strategic acquisition of Xpand Biotechnology B.V. of…